Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Piramal Critical Care Acquires Yargesa from Edenbridge Pharma 14
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 15
Piramal Enterprises Acquires Intrathecal Therapy Business from Mallinckrodt for 203 Million 16
Piramal to Acquire Five Anesthesia and Pain Management Injectable Products from Janssen Pharma 18
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 19
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 20
Piramal Enterprises Acquires Caladryl Brand From Valeant Pharma 21
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 22
Private Equity 23
Piramal Enterprises Mulls Sale of Up to 20% Stake in OTC Drugs Business 23
Partnerships 24
Terumo Enters into Distribution Agreement with Piramal Critical Care 24
Cumberland Pharma Enters into Agreement with Piramal Critical Care 25
Piramal Enterprises Forms Joint Venture with Navin Fluorine International 26
Goodwin Biotech Enters Into Co-Development Agreement With Coldstream Labs For Cytotoxic Antibody Drug Conjugates 27
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 28
Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 29
Licensing Agreements 30
Piramal Imaging Enters into Licensing Agreement with Isologic Innovative Radiopharma 30
AC Immune Enters Into License Agreement With Piramal Imaging 31
Presage Biosciences Enters into Licensing Agreement with Piramal Enterprises 33
Equity Offering 34
Piramal Enterprises Plans to Raise Funds through Public Offering 34
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 35
Debt Offering 36
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 36
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 37
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 38
Asset Transactions 39
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 39
Acquisition 40
Piramal Enterprises Acquires Ash Stevens 40
Piramal Acquires Coldstream for USD30.6 Million 41
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 42
Piramal Healthcare Plans To Acquire Contract Manufacturing Companies 43
Piramal Healthcare Plans To Acquire Pharma Company In Europe 44
Piramal Enterprises Ltd – Key Competitors 45
Piramal Enterprises Ltd – Key Employees 46
Piramal Enterprises Ltd – Locations And Subsidiaries 47
Head Office 47
Other Locations & Subsidiaries 47
Recent Developments 50
Strategy And Business Planning 50
Mar 22, 2017: Piramal Pharma Solutions Augments Integrated Capabilities by Expanding Sterile Manufacturing Capabilities in Lexington, KY 50
Financial Announcements 51
Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018 51
May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018 53
Corporate Communications 55
Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Piramal Enterprises Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Piramal Critical Care Acquires Yargesa from Edenbridge Pharma 14
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 15
Piramal Enterprises Acquires Intrathecal Therapy Business from Mallinckrodt for 203 Million 16
Piramal to Acquire Five Anesthesia and Pain Management Injectable Products from Janssen Pharma 18
Piramal Enterprises Plans to Acquire Over The Counter Business from Morepen Labs 19
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 20
Piramal Enterprises Acquires Caladryl Brand From Valeant Pharma 21
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 22
Piramal Enterprises Mulls Sale of Up to 20% Stake in OTC Drugs Business 23
Terumo Enters into Distribution Agreement with Piramal Critical Care 24
Cumberland Pharma Enters into Agreement with Piramal Critical Care 25
Piramal Enterprises Forms Joint Venture with Navin Fluorine International 26
Goodwin Biotech Enters Into Co-Development Agreement With Coldstream Labs For Cytotoxic Antibody Drug Conjugates 27
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 28
Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 29
Piramal Imaging Enters into Licensing Agreement with Isologic Innovative Radiopharma 30
AC Immune Enters Into License Agreement With Piramal Imaging 31
Presage Biosciences Enters into Licensing Agreement with Piramal Enterprises 33
Piramal Enterprises Plans to Raise Funds through Public Offering 34
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 35
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 36
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 37
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 38
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 39
Piramal Enterprises Acquires Ash Stevens 40
Piramal Acquires Coldstream for USD30.6 Million 41
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 42
Piramal Healthcare Plans To Acquire Contract Manufacturing Companies 43
Piramal Healthcare Plans To Acquire Pharma Company In Europe 44
Piramal Enterprises Ltd, Key Competitors 45
Piramal Enterprises Ltd, Key Employees 46
Piramal Enterprises Ltd, Other Locations 47
Piramal Enterprises Ltd, Subsidiaries 47
List of Figures
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Piramal Enterprises Ltd, Medical Devices Deals, 2012 to YTD 2018 11